{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:14:05Z","timestamp":1778696045267,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,13]]},"DOI":"10.7759\/cureus.108797","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:30:57Z","timestamp":1778693457000},"source":"Crossref","is-referenced-by-count":0,"title":["Compound Heterozygous Sickle Cell-Beta Thalassemia Presenting As Chronic Hemolytic Anemia With Microcytosis and Prominent Left Ventricular Trabeculation: A Case Report"],"prefix":"10.7759","author":[{"given":"Vijay Krishnan","family":"Radhakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswanaa","family":"Kamanuru Govindarajulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilakavathi N","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janani","family":"Nabirajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suganya","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel FB","year":"2017","unstructured":"Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017, 376:1561-73. 10.1056\/NEJMra1510865","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31822-6","article-title":"Thalassaemia","volume":"391","author":"Taher AT","year":"2018","unstructured":"Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018, 391:155-67. 10.1016\/S0140-6736(17)31822-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2015.02.008","article-title":"The compound state: Hb S\/beta-thalassemia","volume":"37","author":"Figueiredo MS","year":"2015","unstructured":"Figueiredo MS. The compound state: Hb S\/beta-thalassemia. Rev Bras Hematol Hemoter. 2015, 37:150-2. 10.1016\/j.bjhh.2015.02.008","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2024.101678","article-title":"Prevalence of sickle cell disease, sickle cell trait and HbS-beta-thalassemia in India: a systematic review and meta-analysis","volume":"28","author":"Rao P","year":"2024","unstructured":"Rao P, Raj EA, Natesan S, Gudi N. Prevalence of sickle cell disease, sickle cell trait and HbS-beta-thalassemia in India: a systematic review and meta-analysis. Clin Epidemiol Glob Health. 2024, 28:101619. 10.1016\/j.cegh.2024.101678","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref5","article-title":"Genetic hemoglobin disorders among the people of Assam: a tertiary care hospital based study","volume":"12","author":"Pathak MS","year":"2023","unstructured":"Pathak MS, Borah MS. Genetic hemoglobin disorders among the people of Assam: a tertiary care hospital based study. Int J Med Res Health Sci. 2023, 12:81-9.","journal-title":"Int J Med Res Health Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216404","article-title":"The current role of hydroxyurea in the treatment of sickle cell anemia","volume":"13","author":"L\u00f3pez Rubio M","year":"2024","unstructured":"L\u00f3pez Rubio M, Arg\u00fcello Marina M. The current role of hydroxyurea in the treatment of sickle cell anemia. J Clin Med. 2024, 13:6404. 10.3390\/jcm13216404","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33594","article-title":"Compound heterogeneous sickle cell-B+ thalassemia incidentally discovered through cytological examination of a fine-needle aspiration specimen from an aneurysmal bone cyst in a young child: a case report","volume":"15","author":"Meliti A","year":"2023","unstructured":"Meliti A, Muftah S, Saleh D, Habibullah N. Compound heterogeneous sickle cell-B+ thalassemia incidentally discovered through cytological examination of a fine-needle aspiration specimen from an aneurysmal bone cyst in a young child: a case report. Cureus. 2023, 15:e33594. 10.7759\/cureus.33594","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-012-0114-0","article-title":"Prevalence of \u03b2-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study","volume":"4","author":"Mohanty D","year":"2013","unstructured":"Mohanty D, Colah RB, Gorakshakar AC, et al.. Prevalence of \u03b2-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013, 4:33-42. 10.1007\/s12687-012-0114-0","journal-title":"J Community Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phoj.2017.10.002","article-title":"Burden of thalassemia in India: the road map for control","volume":"2","author":"Colah R","year":"2017","unstructured":"Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: the road map for control. Pediatr Hematol Oncol J. 2017, 2:79-84. 10.1016\/j.phoj.2017.10.002","journal-title":"Pediatr Hematol Oncol J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12592","article-title":"Prevalence of left ventricular hypertrabeculation\/noncompaction among children with sickle cell disease","volume":"13","author":"Morrison ML","year":"2018","unstructured":"Morrison ML, McMahon C, Tully R, Enright N, Pignatelli R, Towbin JA, McMahon CJ. Prevalence of left ventricular hypertrabeculation\/noncompaction among children with sickle cell disease. Congenit Heart Dis. 2018, 13:440-3. 10.1111\/chd.12592","journal-title":"Congenit Heart Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02114-3","article-title":"Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia","volume":"14","author":"Bonamini R","year":"2019","unstructured":"Bonamini R, Imazio M, Faletti R, et al.. Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia. Intern Emerg Med. 2019, 14:1299-306. 10.1007\/s11739-019-02114-3","journal-title":"Intern Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61282-4","article-title":"Left ventricular non-compaction cardiomyopathy","volume":"386","author":"Towbin JA","year":"2015","unstructured":"Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet. 2015, 386:813-25. 10.1016\/S0140-6736(14)61282-4","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.05.096","article-title":"Left ventricular noncompaction: a distinct genetic cardiomyopathy?","volume":"68","author":"Arbustini E","year":"2016","unstructured":"Arbustini E, Favalli V, Narula N, Serio A, Grasso M. Left ventricular noncompaction: a distinct genetic cardiomyopathy?. J Am Coll Cardiol. 2016, 68:949-66. 10.1016\/j.jacc.2016.05.096","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware RE","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017, 390:311-23. 10.1016\/S0140-6736(17)30193-9","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.36660\/abc.20220207","article-title":"Prevalence of cardiovascular complications in individuals with sickle cell anemia and other hemoglobinopathies: a systematic review","volume":"119","author":"Lopes A","year":"2022","unstructured":"Lopes A, Dantas MT, Ladeia AM. Prevalence of cardiovascular complications in individuals with sickle cell anemia and other hemoglobinopathies: a systematic review. Arq Bras Cardiol. 2022, 119:893-9. 10.36660\/abc.20220207","journal-title":"Arq Bras Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association","volume":"128","author":"Pennell DJ","year":"2013","unstructured":"Pennell DJ, Udelson JE, Arai AE, et al.. Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013, 128:281-308. 10.1161\/CIR.0b013e31829b2be6","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485913-compound-heterozygous-sickle-cell-beta-thalassemia-presenting-as-chronic-hemolytic-anemia-with-microcytosis-and-prominent-left-ventricular-trabeculation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:30:59Z","timestamp":1778693459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485913-compound-heterozygous-sickle-cell-beta-thalassemia-presenting-as-chronic-hemolytic-anemia-with-microcytosis-and-prominent-left-ventricular-trabeculation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.108797","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}